Vinay Prasad, MD
Enriched profileProfessor of Epidemiology and Biostatistics and Medicine, School of Medicine, UCSF · University of California, San Francisco
Vinay Prasad is Professor of Epidemiology and Biostatistics and Medicine, School of Medicine, UCSF at University of California, San Francisco. OpenAlex indexes 608 publications with 16,870 citations (h-index 58).
Data verified 8 Nov 2026
Overview
Updated 8 Nov 2026
Vinay Prasad, MD, is Professor of Epidemiology and Biostatistics and Medicine, School of Medicine, UCSF at University of California, San Francisco. The public record shows 608 publications with 16,870 citations (h-index 58), centered on Statistical Methods in Clinical Trials, Pharmaceutical industry and healthcare, Pharmaceutical Economics and Policy. It also documents industry payments reported by 2 companies.
- Most recent indexed publication: 2025 · Molecular cancer therapeutics
- Top research focus: Statistical Methods in Clinical Trials
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 8 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 44 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 262.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Updated 8 Nov 2026
2 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ConvaTec Inc.Program year20251 payment
- Sonendo IncProgram year20211 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 8 Nov 2026
17 congress contributions (2017–2025) across AGA, ASCO, ASH, ASTRO, ENDO per OpenAlex. The most recent:
- MON-362 Endocrine Immune-Related Adverse Events in Immune Checkpoint Inhibitor Therapy: Insights Across Cancer Types and Treatment Stages
ENDO Annual Meeting
ENDO2025Co-author - Bridging therapies used in trials testing CAR-T therapies.
ASCO Annual Meeting
ASCO2024Presenting authorOnline-only
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 8 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials.
Molecular cancer therapeutics
Article2025 - Characterization of bridging therapies in clinical trials leading to FDA approval of CAR-T cell therapies.
International journal of cancer
Article2025 - Reply to 'Surrogate end points in oncology: aligning drug development incentives and patient needs'.
Nature reviews. Clinical oncology
Letter2025 - The cost of emulated target trials: Is real-world data cheaper than randomized studies?
European journal of clinical investigation
Article2025 - How many people in the US are eligible for and respond to checkpoint inhibitors: An empirical analysis.
International journal of cancer
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practicesEditorial737 citations2014
- 03
- 04The high price of anticancer drugs: origins, implications, barriers, solutionsReview441 citations2017
- 05The Strength of Association Between Surrogate End Points and Survival in OncologyArticle417 citations2015
Network
Updated 8 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 8 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Amp.profiles.ucsf.edu
Writes a Substack and co-writes Sensible Medicine
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 8 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Chicago
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗ - MPH
Johns Hopkins University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
- Chairman's Award in Internal Medicine
given to the graduate with highest marks in Internal Medicine
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vinayakkprasad.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Talmadge King, MD
University of California, San Francisco
Adil Daud, MD
University of California, San Francisco
Emmanuelle Waubant, MD
University of California, San Francisco
Peter Ganz, MD
University of California, San Francisco
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Jaroslaw Maciejewski, MD
Cleveland Clinic